Evidence map›Paper›PMID 35424530›Full record

ArticleRSC advances2021

Li@C

Mathias Wolf, Shuichi Toyouchi, Peter Walke, Kazuki Umemoto, Akito Masuhara, Hiroshi Fukumura, Yuta Takano, Michio Yamada, Kenji Hirai, Eduard Fron and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mathias WolfDivision of Molecular Imaging and Photonics, Department of Chemistry, KU Leuven Celestijnenlaan 200F 3001 Leuven Belgium hiroshi.ujii@kuleuven.be.ORCID https://orcid.org/0000-0002-5228-9454
Shuichi ToyouchiDivision of Molecular Imaging and Photonics, Department of Chemistry, KU Leuven Celestijnenlaan 200F 3001 Leuven Belgium hiroshi.ujii@kuleuven.be.ORCID https://orcid.org/0000-0002-4771-8015
Peter WalkeDivision of Molecular Imaging and Photonics, Department of Chemistry, KU Leuven Celestijnenlaan 200F 3001 Leuven Belgium hiroshi.ujii@kuleuven.be.
Kazuki UmemotoGraduate School of Science and Engineering, Yamagata University Yonezawa Yamagata 992-8510 Japan.ORCID https://orcid.org/0000-0002-1196-1283
Akito MasuharaGraduate School of Science and Engineering, Yamagata University Yonezawa Yamagata 992-8510 Japan.ORCID https://orcid.org/0000-0001-7108-959X
Hiroshi FukumuraDepartment of Chemistry, Graduate School of Science, Tohoku University 6-3 Aramaki, Aoba Sendai 980-8578 Japan.ORCID https://orcid.org/0000-0003-2392-935X
Yuta TakanoRIES, Hokkaido University N20W10, Kita-Ward Sapporo Japan.ORCID https://orcid.org/0000-0001-9469-6253
Michio YamadaDepartment of Chemistry, Tokyo Gakugei University Nukuikitamachi 4-1-1 Koganei Tokyo 184-8501 Japan.ORCID https://orcid.org/0000-0002-6715-4202
Kenji HiraiRIES, Hokkaido University N20W10, Kita-Ward Sapporo Japan.ORCID https://orcid.org/0000-0003-3307-3970
Eduard FronDivision of Molecular Imaging and Photonics, Department of Chemistry, KU Leuven Celestijnenlaan 200F 3001 Leuven Belgium hiroshi.ujii@kuleuven.be.
Hiroshi Uji-IDivision of Molecular Imaging and Photonics, Department of Chemistry, KU Leuven Celestijnenlaan 200F 3001 Leuven Belgium hiroshi.ujii@kuleuven.be.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Organic materials have attracted considerable attention in nonlinear optical (NLO) applications as they have several advantages over inorganic materials, including high NLO response, and fast response time as well as low-cost and easy fabrication. Lithium-containing C

Identifiers

PMID35424530
PMCPMC8978709

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.